Genius Sports (GENI) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $6.35, -3.50% vs the prior close of $6.58.
- Volume 7.42M shares, 1.1x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
GENI slides 3.5% to $6.35. Closed at $6.35, -3.50% vs the prior close of $6.58. Day range $6.24–$6.71, opened at $6.67.
GENI daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — GENI slides 3.5% to $6.35
- Closed at $6.35, -3.50% vs the prior close of $6.58. Day range $6.24–$6.71, opened at $6.67.
- Volume was 7.42M shares, 1.1x its 50-day average of 6.59M.
- Price is -8.4% vs its 50-day average ($6.93) and -1.5% vs its 200-day average ($6.45).
- 52-week range $3.83–$12.39; today's close sits at 29% of that range, 48.7% below the 52-week high.
Oct 15, 2026 — GENI jumps 7.3% to $6.58
- Closed at $6.58, +7.34% vs the prior close of $6.13. Day range $6.05–$6.62, opened at $6.20.
- Volume was 7.04M shares, 1.0x its 50-day average of 6.77M.
- Price is -5.5% vs its 50-day average ($6.96) and +1.7% vs its 200-day average ($6.47).
- 52-week range $3.83–$12.39; today's close sits at 32% of that range, 46.9% below the 52-week high.
Oct 14, 2026 — GENI slides 6.1% to $6.13, 3 down days in a row
- Closed at $6.13, -6.13% vs the prior close of $6.53. Day range $6.03–$6.53, opened at $6.43.
- Volume was 7.75M shares, 1.1x its 50-day average of 6.95M.
- Price is -12.4% vs its 50-day average ($7.00) and -5.6% vs its 200-day average ($6.49).
- 52-week range $3.83–$12.39; today's close sits at 27% of that range, 50.5% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — GENI dips 1.2% to $6.53
- Closed at $6.53, -1.21% vs the prior close of $6.61. Day range $6.50–$6.76, opened at $6.70.
- Volume was 4.32M shares, 0.6x its 50-day average of 7.04M.
- Price is -7.2% vs its 50-day average ($7.03) and +0.2% vs its 200-day average ($6.52).
- 52-week range $3.83–$12.39; today's close sits at 32% of that range, 47.3% below the 52-week high.
Oct 12, 2026 — GENI dips 0.6% to $6.61
- Closed at $6.61, -0.60% vs the prior close of $6.65. Day range $6.43–$6.69, opened at $6.69.
- Volume was 4.96M shares, 0.7x its 50-day average of 7.05M.
- Price is -6.2% vs its 50-day average ($7.04) and +1.1% vs its 200-day average ($6.54).
- 52-week range $3.83–$12.39; today's close sits at 33% of that range, 46.7% below the 52-week high.
Oct 9, 2026 — GENI rises 0.3% to $6.65, 4 up days in a row
- Closed at $6.65, +0.30% vs the prior close of $6.63. Day range $6.42–$6.81, opened at $6.79.
- Volume was 6.43M shares, 0.9x its 50-day average of 7.02M.
- Price is -5.7% vs its 50-day average ($7.05) and +1.4% vs its 200-day average ($6.56).
- 52-week range $3.83–$12.39; today's close sits at 33% of that range, 46.3% below the 52-week high.
- That makes 4 straight gains.
Oct 8, 2026 — GENI jumps 4.6% to $6.63, 3 up days in a row
- Closed at $6.63, +4.57% vs the prior close of $6.34. Day range $6.15–$6.66, opened at $6.33.
- Volume was 7.39M shares, 1.0x its 50-day average of 7.04M.
- Price is -6.1% vs its 50-day average ($7.06) and +0.8% vs its 200-day average ($6.58).
- 52-week range $3.83–$12.39; today's close sits at 33% of that range, 46.5% below the 52-week high.
- That makes 3 straight gains.
Oct 7, 2026 — GENI rises 1.9% to $6.34
- Closed at $6.34, +1.93% vs the prior close of $6.22. Day range $6.04–$6.42, opened at $6.22.
- Volume was 10.21M shares, 1.5x its 50-day average of 7.00M.
- Price is -10.3% vs its 50-day average ($7.07) and -3.9% vs its 200-day average ($6.60).
- 52-week range $3.83–$12.39; today's close sits at 29% of that range, 48.8% below the 52-week high.
Oct 6, 2026 — GENI jumps 3.8% to $6.22
- Closed at $6.22, +3.84% vs the prior close of $5.99. Day range $6.09–$6.40, opened at $6.27.
- Volume was 11.36M shares, 1.6x its 50-day average of 7.02M.
- Price is -12.3% vs its 50-day average ($7.09) and -6.1% vs its 200-day average ($6.62).
- 52-week range $3.83–$12.39; today's close sits at 28% of that range, 49.8% below the 52-week high.
Oct 5, 2026 — GENI dips 0.5% to $5.99
- Closed at $5.99, -0.50% vs the prior close of $6.02. Day range $5.90–$6.31, opened at $5.98.
- Volume was 6.68M shares, 1.0x its 50-day average of 6.96M.
- Price is -15.8% vs its 50-day average ($7.11) and -9.9% vs its 200-day average ($6.64).
- 52-week range $3.83–$12.39; today's close sits at 25% of that range, 51.7% below the 52-week high.
Oct 2, 2026 — GENI jumps 6.0% to $6.02
- Closed at $6.02, +5.99% vs the prior close of $5.68. Day range $5.71–$6.14, opened at $5.77.
- Volume was 7.94M shares, 1.1x its 50-day average of 6.90M.
- Price is -15.5% vs its 50-day average ($7.12) and -9.7% vs its 200-day average ($6.67).
- 52-week range $3.83–$12.39; today's close sits at 26% of that range, 51.4% below the 52-week high.
GENI latest news & SEC filings
Every SEC filing by or about GENI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Castellani Bryan converted options/RSUs into 151,771 shares on Oct 2, 2026; now holds 164,271
- Castellani Bryan had withheld for taxes 53,297 shares at $5.68 (≈$302.73K) on Oct 2, 2026; now holds 110,974
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Russell Thomas sold 50,000 shares at $6.51 (≈$325.56K) on Sep 17, 2026; now holds 471,467
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Locke Mark sold 477,449 shares at $6.58 (≈$3.14M) on Sep 15, 2026; now holds 19,697,767
- Locke Mark sold 272,551 shares at $6.56 (≈$1.79M) on Sep 16, 2026; now holds 19,425,216
- Locke Mark sold 50,000 shares at $6.54 (≈$327.05K) on Sep 17, 2026; now holds 19,375,216
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 17, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 6, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 28, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade GENI
- How much it moves: over the last 20 sessions the average daily move was 3.67% (largest 11.0%). That is a volatile stock.
- Liquidity: about 8.16M shares (≈$51.79M) trade per day on average.
- 52-week position: $6.35 vs a range of $3.83–$12.39 (29% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 16 sales; latest: Thomas Russell sold 50,000 shares on Sep 17, 2026.
- Latest filings: 6-K Aug 6, 2026; 6-K May 7, 2026; 6-K May 1, 2026.
- Listing: NYSE · industry: Services-Miscellaneous Amusement & Recreation.
GENI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 6.67 | 6.71 | 6.24 | 6.35 | 7.42M |
| Oct 15, 2026 | 6.20 | 6.62 | 6.05 | 6.58 | 7.04M |
| Oct 14, 2026 | 6.43 | 6.53 | 6.03 | 6.13 | 7.75M |
| Oct 13, 2026 | 6.70 | 6.76 | 6.50 | 6.53 | 4.32M |
| Oct 12, 2026 | 6.69 | 6.69 | 6.43 | 6.61 | 4.96M |
| Oct 9, 2026 | 6.79 | 6.81 | 6.42 | 6.65 | 6.43M |
| Oct 8, 2026 | 6.33 | 6.66 | 6.15 | 6.63 | 7.39M |
| Oct 7, 2026 | 6.22 | 6.42 | 6.04 | 6.34 | 10.21M |
| Oct 6, 2026 | 6.27 | 6.40 | 6.09 | 6.22 | 11.36M |
| Oct 5, 2026 | 5.98 | 6.31 | 5.90 | 5.99 | 6.68M |
| Oct 2, 2026 | 5.77 | 6.14 | 5.71 | 6.02 | 7.94M |
| Oct 1, 2026 | 5.75 | 5.80 | 5.41 | 5.68 | 7.11M |
| Sep 30, 2026 | 6.15 | 6.15 | 5.71 | 5.73 | 7.98M |
| Sep 29, 2026 | 6.25 | 6.34 | 6.11 | 6.17 | 8.62M |
| Sep 28, 2026 | 6.32 | 6.40 | 6.10 | 6.15 | 7.05M |
| Sep 25, 2026 | 6.15 | 6.57 | 5.96 | 6.44 | 13.89M |
| Sep 24, 2026 | 6.03 | 6.05 | 5.62 | 5.80 | 10.20M |
| Sep 23, 2026 | 6.04 | 6.14 | 5.85 | 6.12 | 10.16M |
| Sep 22, 2026 | 5.94 | 6.22 | 5.71 | 6.08 | 9.38M |
| Sep 21, 2026 | 5.64 | 5.82 | 5.48 | 5.76 | 7.21M |
About Genius Sports
Genius Sports (GENI) is listed on the NYSE and classified by the SEC under “Services-Miscellaneous Amusement & Recreation”. Its business address is in LONDON, United Kingdom. State of incorporation: Guernsey. Fiscal year ends December 31. SEC CIK 1834489.
GENI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Robert J Bach | Director | Mar 18, 2026 |
| Kimberly Ann Bradley | Director | Mar 18, 2026 |
| Daniel Paul Burns | Director | Mar 18, 2026 |
| Kenneth J Kay | Director | Mar 18, 2026 |
| Mark Locke | Chief Executive Officer | Sep 17, 2026 |
| Claire Nooriala | Director | Mar 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Bryan Castellani | Chief Financial Officer | Mar 18, 2026 |
| Jack Davison | Chief Commercial Officer | Mar 24, 2026 |
| Mark Locke | Chief Executive Officer | Sep 17, 2026 |
| Thomas Russell | Chief Legal Officer | Sep 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 17, 2026 | Thomas Russell | Sale | 50,000 | $6.51 |
| Sep 17, 2026 | Thomas Russell | Sale | 50,000 | $6.51 |
| Sep 17, 2026 | Thomas Russell | Sale | 50,000 | $6.51 |
| Sep 17, 2026 | Thomas Russell | Sale | 50,000 | $6.51 |
| Sep 17, 2026 | Mark Locke | Sale | 50,000 | $6.54 |
| Sep 17, 2026 | Mark Locke | Sale | 50,000 | $6.54 |
| Sep 17, 2026 | Mark Locke | Sale | 50,000 | $6.54 |
| Sep 17, 2026 | Mark Locke | Sale | 50,000 | $6.54 |
| Sep 16, 2026 | Mark Locke | Sale | 272,551 | $6.56 |
| Sep 16, 2026 | Mark Locke | Sale | 272,551 | $6.56 |
| Sep 16, 2026 | Mark Locke | Sale | 272,551 | $6.56 |
| Sep 16, 2026 | Mark Locke | Sale | 272,551 | $6.56 |
| Sep 15, 2026 | Mark Locke | Sale | 477,449 | $6.58 |
| Sep 15, 2026 | Mark Locke | Sale | 477,449 | $6.58 |
| Sep 15, 2026 | Mark Locke | Sale | 477,449 | $6.58 |
GENI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
GENI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Services-Miscellaneous Amusement & Recreation
Walt Disney (DIS)DraftKings (DKNG)Vail Resorts (MTN)Madison Square Garden Sports (MSGS)Rush Street Interactive (RSI)Madison Square Garden Entertainment (MSGE)StubHub (STUB)Super Group (SGHC) (SGHC)Brightstar Lottery (BRSL)United Parks & Resorts (PRKS)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on GENI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.